Veeda Clinical Research
 
Japanese Francais
 
Home | Veeda Oncology | Veeda Biometrics |  Sitemap |  Search :  
 
 
Quick Links
 
 
Phase 1 Clinical Trials, Uk and India Clinical Research, CRO
Home » About Us » Key People » Management
Phase 1 Clinical Trials india,UK,Clinical REsearch
Indian CRO,Contract Research Organisations, India,Phase 1 clinical trials
Dr. Richard Taylor
Matt Bowman - President & CEO Veeda Oncology
 

Matt Bowman brings to Veeda Oncology over 25 years of extensive strategic business experience from within the pharmaceutical and CRO industry as well as significant experience in successfully negotiating and completing a wide assortment of business agreements with his previous areas of responsibilities. Past key positions held by Matt include Senior Vice President, CCO of Prologue Research where he was responsible for all business and marketing/sales activities and Senior Vice President of Operations and Marketing at Neoprobe Corporation where he was involved with their oncology and immunological therapeutic portfolio, as well as their oncology instrumentation line for sentinel node biopsy.

Prior to Neoprobe, Matt was with Pharmacia during which time he progressed through the organization as Product Manager, Marketing Manager, Director of Licensing and New Business Development, and Vice President of the Therapeutic Division. Before joining Pharmacia, Matt obtained pharmaceutical experience in sales as well as marketing research.

 
To know more about Veeda services or if you have any query please click here to contact us
 
Back
 
Phase 1 India,Clinical Research,Bioavailability,phase I unit
Bioequivalence,ECG Studies,QTC studies,Phase I/IIa studies
 
 
Disclaimer | ©2005-2010 Veeda Clinical Research Limited
 
Veeda Clinical Research and Veeda Oncology are registered trademarks of Veeda Clinical Research, Inc.
   
 
Ver. 1.76 (Last Updated - 30 June 2010)